{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:26:44Z","timestamp":1787740004446,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272681"],"award-info":[{"award-number":["81272681"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.09.063","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:58:26Z","timestamp":1537405106000},"page":"486-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Lobaplatin suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model"],"prefix":"10.1016","volume":"108","author":[{"given":"Lina","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4835-0336","authenticated-orcid":false,"given":"Yiming","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.09.063_bib0005","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2018.09.063_bib0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N. Engl. J Med."},{"key":"10.1016\/j.biopha.2018.09.063_bib0015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4155\/fmc.13.62","article-title":"Glutamic acid and its derivatives: candidates for rational design of anticancer drugs","volume":"5","author":"Ali","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.063_bib0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/156800911794328457","article-title":"Nano anti-cancer drugs: pros and cons and future perspectives","volume":"11","author":"Ali","year":"2011","journal-title":"Curr. Cancer Drug. Targets"},{"key":"10.1016\/j.biopha.2018.09.063_bib0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.molliq.2017.03.112","article-title":"Insights into the pharmacology of new heterocycles embedded with oxopyrrolidine rings: DNA binding, molecular docking, and anticancer studies","volume":"234","author":"Ali","year":"2017","journal-title":"J Mol. Liq."},{"key":"10.1016\/j.biopha.2018.09.063_bib0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.sla.0000197702.46394.16","article-title":"Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies","volume":"243","author":"Koppe","year":"2006","journal-title":"Ann. Surg."},{"issue":"Aug. (8)","key":"10.1016\/j.biopha.2018.09.063_bib0035","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1245\/s10434-018-6490-x","article-title":"Peritoneal metastases in colorectal cancer","volume":"25","author":"Jacobson","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2018.09.063_bib0040","first-page":"2317","article-title":"Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study","volume":"19","author":"Gilly","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2018.09.063_bib0045","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.09.063_bib0050","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3747\/co.v18i2.663","article-title":"A new standard of care for the management of peritoneal surface malignancy","volume":"18","author":"Mohamed","year":"2011","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.biopha.2018.09.063_bib0055","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.09.063_bib0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/1871520611313020016","article-title":"Platinum compounds: a hope for future cancer chemotherapy","volume":"13","author":"Ali","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.063_bib0065","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1016\/j.bmc.2013.04.018","article-title":"Curcumin-I Knoevenagel\u2019s condensates and their Schiff\u2019s bases as anticancer agents: synthesis, pharmacological and simulation studies","volume":"21","author":"Ali","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.063_bib0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/1389450116666150309115922","article-title":"Heterocyclic scaffolds: centrality in anticancer drug development","volume":"16","author":"Ali","year":"2015","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.biopha.2018.09.063_bib0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/157340613804488297","article-title":"Syntheses, DNA binding and anticancer profiles of L-glutamic acid ligand and its copper(II) and ruthenium(III) complexes","volume":"9","author":"Ali","year":"2013","journal-title":"Med. Chem."},{"key":"10.1016\/j.biopha.2018.09.063_bib0080","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1007\/s00044-012-0133-8","article-title":"Synthesis, DNA binding, hemolytic, and anti-cancer assays of curcumin I-based ligands and their ruthenium(III) complexes","volume":"22","author":"Ali","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.biopha.2018.09.063_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1517\/13543784.10.1.119","article-title":"Lobaplatin: a new antitumour platinum drug","volume":"10","author":"McKeage","year":"2001","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.biopha.2018.09.063_bib0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2014.12.011","article-title":"Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro","volume":"69","author":"Yang","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.09.063_bib0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.biopha.2013.10.004","article-title":"Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell line CaSki","volume":"68","author":"Li","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.09.063_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biopha.2011.09.008","article-title":"Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE","volume":"66","author":"Wang","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.09.063_bib0105","doi-asserted-by":"crossref","unstructured":"Lobaplatin: D 19466. Drugs R D 2003;4:369.","DOI":"10.2165\/00126839-200304060-00008"},{"key":"10.1016\/j.biopha.2018.09.063_bib0110","first-page":"1131","article-title":"[Clinical study on chemotherapy of lobaplatin combined with docetaxel in patients with relapsed ovarian cancer]","volume":"39","author":"Li","year":"2014","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.biopha.2018.09.063_bib0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12885-017-3080-4","article-title":"Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial","volume":"17","author":"Ke","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2018.09.063_bib0120","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12957-016-1004-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies","volume":"14","author":"Wu","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2018.09.063_bib0125","first-page":"1006","article-title":"[Safety evaluation of intraoperative peritoneal chemotherapy with lobaplatin for advanced colorectal cancers]","volume":"18","author":"Feng","year":"2015","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"10.1016\/j.biopha.2018.09.063_bib0130","doi-asserted-by":"crossref","first-page":"8113","DOI":"10.1039\/c0dt00292e","article-title":"The status of platinum anticancer drugs in the clinic and in clinical trials","volume":"39","author":"Wheate","year":"2010","journal-title":"Dalton Trans."},{"key":"10.1016\/j.biopha.2018.09.063_bib0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biopha.2010.12.001","article-title":"Lobaplatin suppresses proliferation and induces apoptosis in the human colorectal carcinoma cell line LOVO in vitro","volume":"65","author":"Dai","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.09.063_bib0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1349-7006.2003.tb01345.x","article-title":"Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal","volume":"94","author":"Tsuruo","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2018.09.063_bib0145","first-page":"8563","article-title":"Harnessing apoptosis for improved anticancer gene therapy","volume":"63","author":"Waxman","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2018.09.063_bib0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","article-title":"Cytochrome c and dATP-dependent formation of apaf-1\/caspase-9 complex initiates an apoptotic protease cascade","volume":"91","author":"Li","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.09.063_bib0155","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1523\/JNEUROSCI.21-24-09519.2001","article-title":"Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease","volume":"21","author":"Viswanath","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2018.09.063_bib0160","doi-asserted-by":"crossref","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","article-title":"Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant","volume":"273","author":"Oliver","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.09.063_bib0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2017.08.119","article-title":"Antitumor activity of lobaplatin against esophageal squamous cell carcinoma through caspase-dependent apoptosis and increasing the Bax\/Bcl-2 ratio","volume":"95","author":"Du","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.09.063_bib0170","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/bjc.2014.369","article-title":"Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review","volume":"111","author":"Sloothaak","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2018.09.063_bib0175","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andre","year":"2009","journal-title":"J Clin. Oncol."},{"key":"10.1016\/j.biopha.2018.09.063_bib0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jso.24476","article-title":"Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: a systematic review","volume":"115","author":"Feingold","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2018.09.063_bib0185","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.09.063_bib0190","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s00432-017-2489-0","article-title":"Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)","volume":"143","author":"Zhang","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218351497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218351497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:43:50Z","timestamp":1777272230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218351497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":38,"alternative-id":["S0753332218351497"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.063","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lobaplatin suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}